Murray, P
What's next for GLP-1 innovation: A primer on the race reshaping pharma and chronic disease care Brandon Aylward Oct 16, 2025 10 min read Few categories in modern medicine have captured the imagination of patients, physicians, and investors as quickly as GLP-1 receptor agonists (GLP-1s)
If you keep up with all things aesthetic trends, you know that the age of GLP-1s has ushered in a whole new era of cosmetic treatment prioritiesmost notably, the so-called "Ozempic face." While the weight loss drugs in the GLP-1 category are beloved for their fat-burning capabilities, the facial volume loss that can accompany rapid weight loss has become a less-welcome side effect
Retatrutide Dosing: Pharmacological Foundations Mechanism-Driven Dosing Considerations The triple-agonist nature of retatrutide creates unique dosing requirements compared to single or dual-agonist peptides: Key insight : Effective retatrutide dosing must achieve sufficient plasma concentrations to engage all three receptors, not just the highest-affinity GLP-1 target
The Pendulum probiotic is formulated with beneficial bacterial strains known to stimulate GLP-1 production (based on preclinical studies), and reduce appetite and cravings
Patients often present with resistance to the initiation of an injectable agent
